Free CME from PeerView


Oncology CME

Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Across Treatment Settings
Sumanta Kumar Pal, MD, FASCO
November 11, 2023
Credits: 0.5 CME / MOC / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Making Choices, Improving Outcomes in Pediatric ALL: The Role of Modern Asparaginase Compounds
Luke Maese, DO
November 09, 2023
Credits: 1.5 CME / NCPD / CPE / AAPA
PVI, PeerView Institute for Medical Education
Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care
Beth Sandy, MSN, CRNP, FAPO
November 09, 2023
Credits: 1.0 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Optimizing the Care of Patients With SCLC in the Community Setting: How to Make the Most of the Latest Therapeutic Advances and Team-Based Best Practices
Ticiana Leal, MD
October 30, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence With Non-Covalent BTK Inhibitors in R/R Disease
Nirav Shah, MD, MS / Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD
October 26, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Choosing Wisely, Achieving Control With BTKi in CLL: Perspectives on Safety-Informed Approaches to Enhanced Therapeutic Efficacy
John C. Byrd, MD
October 07, 2023
Credits: 1.5 CME / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Tumor Treating Fields as an Innovative Modality of Cancer Therapy: From CNS to Thoracic Malignancies and Beyond
Erik P. Sulman, MD, PhD
October 01, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Command and Control MDS: New Science in MDS Management and Implications for Veteran-Centered Care
Michael R. Savona, MD / Andrew M. Brunner, MD
September 28, 2023
Credits: 0.75 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: Leveraging Science, Enhancing Collaboration, and Improving Outcomes With Neoadjuvant and/or Adjuvant Checkpoint Inhibition
Jessica Donington, MD
September 22, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens
Melissa L. Johnson, MD
September 11, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
A Bold Frontier: Shattering the Limits of Conventional Therapies and Reshaping the Future of Lung Cancer Treatment With TROP2-Targeting ADCs and Rational Combinations
Stephen V. Liu, MD
September 08, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Level Up With Personalized Care for CLL/SLL: Achieving Better Total Care With Targeted Agents & Innovative Combinations
William G. Wierda, MD, PhD / Nicole Lamanna, MD
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Expanding the Circle of Personalized AML Treatment: Expert Consults on Integrating Precision Medicine With Innovative Treatment Platforms
Naval Daver, MD / Gail J. Roboz, MD
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The Commanding Heights of MDS Care: Team Strategies for Delivering Modern Personalized Therapy
Guillermo Garcia-Manero, MD / Amy E. DeZern, MD, MHS
September 06, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Setting New Expectations in Multiple Myeloma: Guidance on BCMA CAR-T & Antibody Options to Enhance Patient Care
Sagar Lonial, MD, FACP / Krina Patel, MD, MSc
September 06, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Can YOU Avoid Iatrogenic Harm? Understanding and Identifying Fibrodysplasia Ossificans Progressiva
Richard Keen, PhD, FRCP / Edna E. Mancilla, MD
August 30, 2023
Credits: 1.0 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Selective, Potent, Different: How to Enhance Clinical Benefits With Next-Generation ROS1 and TRK Inhibition in Treatment-Naïve and Pretreated NSCLC and Other Tumors
Alexander Drilon, MD
August 08, 2023
Credits: 1.0 CME / MOC / CC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Taking Direction From Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges With Continuous BTKi Therapy
Jennifer Woyach, MD
August 01, 2023
Credits: 0.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
Mark J. Levis, MD, PhD
August 01, 2023
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC: The Latest Evidence and Practical Guidance for Biomarker Testing and Individualized Treatment Selection and Sequencing
Pasi A. Jänne, MD, PhD
July 19, 2023
Credits: 1.0 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
The Team Takes Command in MDS: Guidance on Diagnostic and Treatment Principles for Risk-Based Care and Beyond
Guillermo Garcia-Manero, MD
July 03, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Leading the Change in Hemophilia A: Guidance on Enhancing Prophylactic Care With Innovative EHL FVIII Products
Steven W. Pipe, MD / Maria Elisa Mancuso, MD, PhD
June 23, 2023
Credits: 0.75 CME
PVI, PeerView Institute for Medical Education
“Intensity” With Efficacy in Acute Myeloid Leukemia (AML): Developing Modern, Intensive Upfront Platforms for Challenging Disease Presentations
Prof. Thomas Cluzeau, MD, PhD
June 21, 2023
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Taking the Leap in MCL: New Opportunities With BTK Inhibitors and Other Innovative Strategies
Prof. Dr. Martin Dreyling
June 18, 2023
Credits: 1.0 CME / MOC / CC / AAPA
PVI, PeerView Institute for Medical Education
Polishing Management Protocols in HER2-Expressing GI Cancers With Targeted Agents: A Focus on Refining Team-Based Strategies to Individualize BTC and GEA Care
Elena Elimova, MD, M.Sc., FRcPC
June 08, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Progress on the Path to Improving Outcomes in the Treatment of SCLC: Making the Most of Current Standard-of-Care Therapies and Exploring New Promising Research
Taofeek K. Owonikoko, MD, PhD
June 04, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
Naval Daver, MD
June 03, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms & Emerging Therapeutics
Ruben A. Mesa, MD, FACP
June 03, 2023
Credits: 1.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Endometrial Cancer Care in the Age of Immunotherapy: Translating Clinical Evidence Into Meaningful Improvements in Patient Outcomes Across the Disease Continuum
David M. O'Malley, MD
June 03, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Immunotherapy for the Win Against Melanoma: Strategies for Integrating Innovative and Next-Generation Immunotherapy Options
Jason J. Luke, MD, FACP
June 03, 2023

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView